Hailey Bieber, Kendall Jenner and NAD+ IVs: What to Ask Before Booking in Seoul
Celebrity reports explain the interest in NAD+ infusions. Human research, the exact product and a clinician’s assessment should guide the questions you ask next.

Hailey Bieber and Kendall Jenner helped make NAD+ IVs a celebrity wellness talking point. Their appearance in coverage of the treatment is a starting point for understanding the trend, not evidence that an infusion slows aging or that the same intervention is appropriate during your Seoul trip.
In a December 17, 2024 feature, Vogue reported that Bieber and Jenner were filmed receiving NAD+ intravenous drips in The Kardashians. This article attributes that account to Vogue; it does not independently verify their medical records, formulation, dose or later use. The report does not connect either person to a Korean provider.
Keep the celebrity story separate from the product
A photograph of a public figure cannot identify what is in an IV bag. Nor can a report about one person establish which product another clinic uses. The portrait here was taken at the 2018 Billboard Music Awards, outside any treatment setting. The catheter photograph illustrates an actual IV route; it does not show either celebrity, NAD+ administration or Seolreim Clinic.
NAD+ means nicotinamide adenine dinucleotide, a molecule involved in cellular metabolism. A molecule’s role in the body and the outcome of administering it as a commercial infusion are different questions. Ask for the full ingredient list rather than relying on labels such as longevity drip, energy infusion or celebrity treatment.
What the human research actually examined
A 2019 pilot study by Grant and colleagues investigated changes in plasma and urine NAD-related metabolites during a six-hour intravenous infusion. It examined metabolism under a specific protocol. It was not a demonstration that a wellness drip makes skin younger or prolongs life. A measured biomarker and a visible or long-term clinical benefit are not interchangeable outcomes.
A February 2, 2026 retrospective pilot by Reyna and colleagues compared commercially administered NAD+ and nicotinamide riboside, or NR, infusions. It examined tolerability and short-term safety markers with 30-day follow-up. Participants receiving NAD+ reported infusion symptoms including gastrointestinal discomfort, increased heart rate and chest pressure. The authors called for further research on dosage and effectiveness beyond that period.

NR is a different substance from NAD+. Results for one infusion or an oral precursor should not be presented as proof for another product or route. Neither of these small pilot studies establishes the broad anti-aging promise often attached to the celebrity trend.
An IV also raises product-quality questions
The US FDA’s October 30, 2024 notice warned about food-grade NAD+ being used to prepare sterile intravenous products without appropriate processing. It reported severe chills, shaking, vomiting and fatigue after NAD+ injections, with some cases requiring treatment; the reactions were consistent with excessive endotoxin levels. That notice concerns preparation quality and reported adverse events, rather than proving that every NAD+ formulation causes the same reaction.
The US notice does not establish a product’s Korean authorization or a Korean clinic’s practices. For an appointment in Seoul, ask the clinician to identify the actual product, supplier, ingredients and Korean regulatory status, and to explain the proposed purpose, uncertainties and alternatives. A foreign celebrity report is not a substitute for that information.
Five questions to take to a Seoul consultation
- What exact substance and formulation are proposed: NAD+, NR, another ingredient or a mixture?
- What evidence supports the specific goal being discussed, and what remains uncertain?
- How does my medical history, medication and supplement list affect suitability? Include pregnancy, breastfeeding or pregnancy plans when relevant.
- Who will assess me, administer the infusion and respond to symptoms during or after it?
- Can I receive written product and treatment records, aftercare and a contact method that works after I leave Korea?
Do not choose a dose, infusion rate or repeat schedule from a celebrity anecdote. If an infusion is proposed, agree in advance how symptoms will be monitored and when treatment would be stopped or medical assessment obtained. Leave room in your itinerary for review rather than assuming a drip is equivalent to a casual shopping appointment.
The partnership panel below provides separate Seolreim Clinic contact links. It does not establish that the clinic offers a particular NAD+ product or that the celebrities reported above have visited or endorsed it. Use a consultation to ask about availability and suitability, and request a written explanation before deciding whether to proceed.


